-
Reducing API dependence: Have we got the strategy right?
expresspharma
November 04, 2020
Reji K Joseph, Associate Professor, Institute for Studies in Industrial Development, New Delhi explains that the PLI scheme has some gaps that need to be plugged for it to be truly successful.
-
Pharma industry appreciates modification in PLI scheme, seek more support
expresspharma
November 02, 2020
The industry also raises concerns related to brownfield investments, protection of indigenous manufacturing.
-
Aarti Drugs to expand metformin capacity to 3000 TPM
expresspharma
November 02, 2020
Aarti Drugs has procured land to expand its existing Metformin Capacity to 3000 TPM in a brownfield expansion. This expansion would be a two-phase expansion program.
-
CordenPharma Colorado Completes Highly Potent API Lab Expansion
contractpharma
October 21, 2020
CordenPharma has completed a new highly potent active pharmaceutical ingredient (API) laboratory in its Boulder, CO, facility.
-
Biopharma companies more optimistic about 2020 imports/exports than in Q1: GlobalData
expresspharma
October 19, 2020
API manufacturing still remains a greater concern than finished dose due to the high volume of small molecule API produced in China and India for cost reasons.
-
More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates: Premchand Godha
expresspharma
October 10, 2020
Policies, schemes should be designed keeping overall drug industry in mind, said the Chairman and MD of Ipca Laboratories.
-
Majority of generic drug ingredients produced in Asia – study
expresspharma
October 10, 2020
Industry players warn bringing production home may be a complicated process, saying higher labour costs and tougher environmental standards make it impossible to compete with Asian suppliers on price.
-
Research finds 25 percent of drugs contain highly potent compounds
europeanpharmaceuticalreview
September 27, 2020
A new report has said that a quarter of drugs globally are based on highly potent active pharmaceutical ingredients.
-
India ramping up API manufacturing: NITI Aayog CEO
expresspharma
September 17, 2020
Indian government is committed to achieving its ''Pharma Vision 2020'', which aims to make the country a global leader in drug discovery, innovation, and drug manufacturing, said Kant.
-
CORONA Remedies picks up stake in La Chandra Pharmalab
expresspharma
September 08, 2020
La Chandra Pharmalab is a manufacturer and supplier of pregnancy care drug progesterone and a range of hormone APIs.